Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.

Saved in:
Bibliographic Details
Title: Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Authors: Marzinke MA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wang Z; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kofron R; Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Moser A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bhandari P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gollings R; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bushman LR; Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA., Weng L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Halvas EK; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mellors J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Anderson PL; Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA., Persaud D; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Hendrix CW; Department of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., McCauley M; FHI 360, Durham, North Carolina, USA., Rinehart AR; ViiV Healthcare, Research Triangle Park, North Carolina, USA., St Clair M; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Ford SL; GlaxoSmithKline, Research Triangle Park, North Carolina, USA., Rooney JF; Gilead Sciences, Foster City, California, USA., Adeyeye A; Prevention Science Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Chariyalertsak S; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand., Mayer K; The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Arduino RC; Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Cohen MS; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Grinsztejn B; Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Hanscom B; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Landovitz RJ; Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, California, USA., Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Apr 18; Vol. 67 (4), pp. e0005323. Date of Electronic Publication: 2023 Mar 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00053-23